We are live on ! Find out more
TCM

Traynor Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 62.36%
This Fund
S&P 500
This Quarter Est. Return
+16.53%
1 Year Est. Return
+62.36%
3 Year Est. Return
+225.14%
5 Year Est. Return
+309.6%
10 Year Est. Return
+1,325.9%
AUM
$973M
AUM Growth
+$175M
Cap. Flow
+$46.7M
Cap. Flow %
4.8%
Top 10 Hldgs %
56.24%
Holding
269
New
43
Increased
99
Reduced
86
Closed
24

Top Sells

Rank Stock Value
1
F icon
Ford
F
+$3.16M
2
IVW icon
iShares S&P 500 Growth ETF
IVW
+$3.14M
3
IVE icon
iShares S&P 500 Value ETF
IVE
+$2.98M
4
ENPH icon
Enphase Energy
ENPH
+$2.27M
5
NVDA icon
NVIDIA
NVDA
+$1.62M

Sector Composition

Rank Sector Weight
1 Technology 26.36%
2 Consumer Discretionary 12.44%
3 Communication Services 12.09%
4 Healthcare 7.63%
5 Industrials 5.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISTB icon
201
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.13B
$203K 0.02%
+4,274
New +$200K
VTWO icon
202
Vanguard Russell 2000 ETF
VTWO
$17.4B
$203K 0.02%
+2,502
New +$181K
EOS
203
Eaton Vance Enhance Equity Income Fund II
EOS
$1.18B
$201K 0.02%
10,730
-2,090
-16% -$37K
RIG icon
204
Transocean
RIG
$5.82B
$201K 0.02%
31,607
-400
-1% -$2.68K
SOFI icon
205
SoFi Technologies
SOFI
$23.7B
$196K 0.02%
19,660
+2,304
+13% +$18.3K
RIVN icon
206
CALL
Rivian
RIVN
$23.2B
$188K 0.02%
8,000
+2,000
+33% +$37.6K
NEE icon
207
CALL
NextEra Energy
NEE
$177B
$182K 0.02%
+3,000
New +$171K
TDOC icon
208
CALL
Teladoc Health
TDOC
$1.3B
$172K 0.02%
+8,000
New +$148K
IONQ icon
209
CALL
IonQ
IONQ
$16.6B
$149K 0.02%
12,000
+4,000
+50% +$51.6K
NVDA icon
210
CALL
NVIDIA
NVDA
$5.42T
$149K 0.02%
3,000
NEXT icon
211
NextDecade
NEXT
$1.78B
$143K 0.01%
30,001
RIVN icon
212
Rivian
RIVN
$23.2B
$129K 0.01%
5,507
-186
-3% -$3.5K
DMTK
213
CALL
DELISTED
DermTech, Inc. Common Stock
DMTK
$123K 0.01%
70,500
SIRI icon
214
SiriusXM
SIRI
$10.1B
$117K 0.01%
2,134
+2
+0.1% +$96
AMC icon
215
AMC Entertainment Holdings
AMC
$2.31B
$114K 0.01%
18,695
-986
-5% -$8K
IBRX icon
216
ImmunityBio
IBRX
$8.1B
$85.6K 0.01%
17,050
+2,100
+14% +$6.59K
PSEC icon
217
Prospect Capital
PSEC
$1.17B
$84.3K 0.01%
14,071
+124
+0.9% +$714
TLRY icon
218
Tilray
TLRY
$622M
$79.1K 0.01%
3,437
+2
+0.1% +$39
BNKK
219
Bonk Inc
BNKK
$8.4M
$75.5K 0.01%
+614
New +$57.8K
NIO icon
220
NIO
NIO
$11.9B
$57.8K 0.01%
6,370
+1,042
+20% +$8.27K
GALT icon
221
Galectin Therapeutics
GALT
$348M
$57.6K 0.01%
34,707
PLTR icon
222
CALL
Palantir
PLTR
$413B
$51.5K 0.01%
3,000
+1,000
+50% +$17.8K
STEM icon
223
Stem
STEM
$52.7M
$46.7K ﹤0.01%
+602
New +$41.5K
TDOC icon
224
Teladoc Health
TDOC
$1.3B
$38.9K ﹤0.01%
+1,803
New +$33.3K
PCT icon
225
PureCycle Technologies
PCT
$1.45B
$38.2K ﹤0.01%
+9,440
New +$41.5K

Similar funds

Traynor Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Traynor Capital Management held 269 positions worth $973M, up 22% from $798M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Traynor Capital Management deployed $46.7M of net new capital in Q4 2023, opening 43 new positions and adding to 99 existing holdings. Its largest new stake was Fidelity Value Factor ETF: 55,703 shares worth $2.95M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Ford, an estimated $3.16M trimmed.

  • Traynor Capital Management's largest Q4 2023 buy was Fidelity Value Factor ETF: 55,703 shares worth $2.95M.
  • Traynor Capital Management added most to Eli Lilly in Q4 2023, an estimated $3.04M increase.
  • Traynor Capital Management's biggest Q4 2023 reduction was Ford, cutting an estimated $3.16M.
  • Traynor Capital Management fully exited iShares ESG Aware MSCI EAFE ETF in Q4 2023, selling an estimated $368K.
  • Traynor Capital Management's ten largest holdings make up 56% of its $973M portfolio in Q4 2023.
  • Traynor Capital Management opened 43 new positions and closed 24 in Q4 2023.
  • Traynor Capital Management's portfolio value rose 22% quarter-over-quarter to $973M.

Based on Traynor Capital Management's 13F filing for Q4 2023, filed 18 Jan 2024.